Skip to main content

2014 | OriginalPaper | Buchkapitel

20. Urothelkarzinom des oberen Harntrakts

verfasst von : J. Simon, J.E. Gschwend

Erschienen in: Facharztwissen Urologie

Verlag: Springer Berlin Heidelberg

Zusammenfassung

Etwa 5–7% der Urothelkarzinome entwickeln sich im oberen Harntrakt. Die Risikofaktoren entsprechen weitgehend denen für das Harnblasenkarzinom. Standard in der Bildgebung des oberen Harntrakts ist das mehrphasige Multi-Detektor-CT mit Exkretionsphase. In Fällen diagnostischer Unsicherheit ist immer eine diagnostische Ureterorenoskopie mit histologischer Sicherung der Malignität anzustreben. Je nach Ausmaß und Lokalisation des Urothelkarzinoms sind organerhaltende Verfahren oder eine radikale Nephroureterektomie indiziert.
Literatur
Zurück zum Zitat Capitanio U, Shariat SF, Isbarn H et al. (2009) Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases. Eur Urol 56 (1): 1–9PubMedCrossRef Capitanio U, Shariat SF, Isbarn H et al. (2009) Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases. Eur Urol 56 (1): 1–9PubMedCrossRef
Zurück zum Zitat Chen B, Zeng ZC, Wang GM et al. (2011) Radiotherapy may improve overall survival of patients with T3/T4 transitional cell carcinoma of the renal pelvis or ureter and delay bladder tumour relapse. BMC Cancer 11: 297PubMedCentralPubMedCrossRef Chen B, Zeng ZC, Wang GM et al. (2011) Radiotherapy may improve overall survival of patients with T3/T4 transitional cell carcinoma of the renal pelvis or ureter and delay bladder tumour relapse. BMC Cancer 11: 297PubMedCentralPubMedCrossRef
Zurück zum Zitat Czito B, Zietman A, Kaufman D, Skowronski U, Shipley W. (2004) Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter. J Urol 172 (4 Pt 1): 1271–1275.PubMedCrossRef Czito B, Zietman A, Kaufman D, Skowronski U, Shipley W. (2004) Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter. J Urol 172 (4 Pt 1): 1271–1275.PubMedCrossRef
Zurück zum Zitat Elliott DS, Blute ML, Patterson DE, Bergstralh EJ, Segura JW (1996) Long-term follow-up of endoscopically treated upper urinary tract transitional cell carcinoma. Urology 47 (6): 819–825PubMedCrossRef Elliott DS, Blute ML, Patterson DE, Bergstralh EJ, Segura JW (1996) Long-term follow-up of endoscopically treated upper urinary tract transitional cell carcinoma. Urology 47 (6): 819–825PubMedCrossRef
Zurück zum Zitat Guarnizo E, Pavlovich CP, Seiba M, Carlson DL, Vaughan EDJ, Sosa RE (2000) Ureteroscopic biopsy of upper tract urothelial carcinoma: improved diagnostic accuracy and histopathological considerations using a multi-biopsy approach. J Urol 163 (1): 52–55PubMedCrossRef Guarnizo E, Pavlovich CP, Seiba M, Carlson DL, Vaughan EDJ, Sosa RE (2000) Ureteroscopic biopsy of upper tract urothelial carcinoma: improved diagnostic accuracy and histopathological considerations using a multi-biopsy approach. J Urol 163 (1): 52–55PubMedCrossRef
Zurück zum Zitat Guinan P, Vogelzang NJ, Randazzo R et al. (1992) Renal pelvic cancer: a review of 611 patients treated in Illinois 1975-1985. Cancer Incidence and End Results Committee. Urology 40 (5): 393–399PubMedCrossRef Guinan P, Vogelzang NJ, Randazzo R et al. (1992) Renal pelvic cancer: a review of 611 patients treated in Illinois 1975-1985. Cancer Incidence and End Results Committee. Urology 40 (5): 393–399PubMedCrossRef
Zurück zum Zitat Gurbuz C, Youssef RF, Shariat SF et al. (2011) The impact of previous ureteroscopic tumor ablation on oncologic outcomes after radical nephrouretectomy for upper urinary tract urothelial carcinoma. J Endourol 25 (5): 775–779PubMedCrossRef Gurbuz C, Youssef RF, Shariat SF et al. (2011) The impact of previous ureteroscopic tumor ablation on oncologic outcomes after radical nephrouretectomy for upper urinary tract urothelial carcinoma. J Endourol 25 (5): 775–779PubMedCrossRef
Zurück zum Zitat Hall MC, Womack S, Sagalowsky AI, Carmody T, Erickstad MD, Roehrborn CG (1998) Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology 52 (4): 594–601PubMedCrossRef Hall MC, Womack S, Sagalowsky AI, Carmody T, Erickstad MD, Roehrborn CG (1998) Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology 52 (4): 594–601PubMedCrossRef
Zurück zum Zitat Hellenthal NJ, Shariat SF, Margulis V et al. (2009) Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration. J Urol 182 (3): 900–906PubMedCrossRef Hellenthal NJ, Shariat SF, Margulis V et al. (2009) Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration. J Urol 182 (3): 900–906PubMedCrossRef
Zurück zum Zitat Huang WT, Li LY, Pang J et al. (2012) Fluorescence in situ hybridization assay detects upper urinary tract transitional cell carcinoma in patients with asymptomatic hematuria and negative urine cytology. Neoplasma 59 (4): 355–360PubMedCrossRef Huang WT, Li LY, Pang J et al. (2012) Fluorescence in situ hybridization assay detects upper urinary tract transitional cell carcinoma in patients with asymptomatic hematuria and negative urine cytology. Neoplasma 59 (4): 355–360PubMedCrossRef
Zurück zum Zitat Kang CH, Yu TJ, Hsieh HH et al. (2003) The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract. Cancer 98 (8): 1620–1626PubMedCrossRef Kang CH, Yu TJ, Hsieh HH et al. (2003) The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract. Cancer 98 (8): 1620–1626PubMedCrossRef
Zurück zum Zitat Kondo T, Hashimoto Y, Kobayashi H et al. (2010) Template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract: impact on patient survival. Int J Urol 17 (10): 848–854PubMedCrossRef Kondo T, Hashimoto Y, Kobayashi H et al. (2010) Template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract: impact on patient survival. Int J Urol 17 (10): 848–854PubMedCrossRef
Zurück zum Zitat Lane BR, Smith AK, Larson BT et al. (2010) Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy. Cancer 116 (12): 2967–2973.PubMedCrossRef Lane BR, Smith AK, Larson BT et al. (2010) Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy. Cancer 116 (12): 2967–2973.PubMedCrossRef
Zurück zum Zitat Lehmann J, Suttmann H, Kovac I et al. (2007) Transitional cell carcinoma of the ureter: prognostic factors influencing progression and survival. Eur Urol 51 (5): 1281–1288PubMedCrossRef Lehmann J, Suttmann H, Kovac I et al. (2007) Transitional cell carcinoma of the ureter: prognostic factors influencing progression and survival. Eur Urol 51 (5): 1281–1288PubMedCrossRef
Zurück zum Zitat Lughezzani G, Jeldres C, Isbarn H et al. (2010) A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma. Urology 75 (1): 118–124PubMedCrossRef Lughezzani G, Jeldres C, Isbarn H et al. (2010) A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma. Urology 75 (1): 118–124PubMedCrossRef
Zurück zum Zitat Morioka M, Jo Y, Furukawa Y et al. (2001) Prognostic factors for survival and bladder recurrence in transitional cell carcinoma of the upper urinary tract. Int J Urol 8 (7): 366–373PubMedCrossRef Morioka M, Jo Y, Furukawa Y et al. (2001) Prognostic factors for survival and bladder recurrence in transitional cell carcinoma of the upper urinary tract. Int J Urol 8 (7): 366–373PubMedCrossRef
Zurück zum Zitat O’Brien T, Ray E, Singh R, Coker B, Beard R. (2011) Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial). Eur Urol 60 (4): 703–710PubMedCrossRef O’Brien T, Ray E, Singh R, Coker B, Beard R. (2011) Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial). Eur Urol 60 (4): 703–710PubMedCrossRef
Zurück zum Zitat Racioppi M, D’Addessi A, Alcini A, Destito A, Alcini E. (1997) Clinical review of 100 consecutive surgically treated patients with upper urinary tract transitional tumours. Br J Urol 80 (5): 707–711PubMedCrossRef Racioppi M, D’Addessi A, Alcini A, Destito A, Alcini E. (1997) Clinical review of 100 consecutive surgically treated patients with upper urinary tract transitional tumours. Br J Urol 80 (5): 707–711PubMedCrossRef
Zurück zum Zitat Rey A, Lara PC, Redondo E, Valdes E, Apolinario R. (1997) Overexpression of p53 in transitional cell carcinoma of the renal pelvis and ureter. Relation to tumor proliferation and survival. Cancer 79 (11): 2178–2185PubMedCrossRef Rey A, Lara PC, Redondo E, Valdes E, Apolinario R. (1997) Overexpression of p53 in transitional cell carcinoma of the renal pelvis and ureter. Relation to tumor proliferation and survival. Cancer 79 (11): 2178–2185PubMedCrossRef
Zurück zum Zitat Roscigno M, Shariat SF, Margulis V et al. (2009) Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. J Urol 181 (6): 2482–2489PubMedCrossRef Roscigno M, Shariat SF, Margulis V et al. (2009) Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. J Urol 181 (6): 2482–2489PubMedCrossRef
Zurück zum Zitat Roupret M, Zigeuner R, Palou J et al. (2011) European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. Eur Urol 59 (4): 584–594PubMedCrossRef Roupret M, Zigeuner R, Palou J et al. (2011) European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. Eur Urol 59 (4): 584–594PubMedCrossRef
Zurück zum Zitat Shiraishi K, Eguchi S, Mohri J, Kamiryo Y. (2003) Role of ureteroscopic biopsy in the management of upper urinary tract malignancy. Int J Urol 10 (12): 627–630PubMedCrossRef Shiraishi K, Eguchi S, Mohri J, Kamiryo Y. (2003) Role of ureteroscopic biopsy in the management of upper urinary tract malignancy. Int J Urol 10 (12): 627–630PubMedCrossRef
Zurück zum Zitat Simone G, Papalia R, Guaglianone S et al. (2009) Laparoscopic versus open nephroureterectomy: perioperative and oncologic outcomes from a randomised prospective study. Eur Urol 56 (3): 520–526PubMedCrossRef Simone G, Papalia R, Guaglianone S et al. (2009) Laparoscopic versus open nephroureterectomy: perioperative and oncologic outcomes from a randomised prospective study. Eur Urol 56 (3): 520–526PubMedCrossRef
Zurück zum Zitat Wang LJ, Wong YC, Ng KF, Chuang CK, Lee SY, Wan YL. (2010) Tumor characteristics of urothelial carcinoma on multidetector computerized tomography urography. J Urol 183 (6): 2154–2160PubMedCrossRef Wang LJ, Wong YC, Ng KF, Chuang CK, Lee SY, Wan YL. (2010) Tumor characteristics of urothelial carcinoma on multidetector computerized tomography urography. J Urol 183 (6): 2154–2160PubMedCrossRef
Metadaten
Titel
Urothelkarzinom des oberen Harntrakts
verfasst von
J. Simon
J.E. Gschwend
Copyright-Jahr
2014
Verlag
Springer Berlin Heidelberg
DOI
https://doi.org/10.1007/978-3-642-44942-0_20

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.